Filing Details
- Accession Number:
- 0001209191-20-004918
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-24 18:10:41
- Reporting Period:
- 2020-01-23
- Accepted Time:
- 2020-01-24 18:10:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1108205 | Curis Inc | CRIS | Biological Products, (No Disgnostic Substances) (2836) | 043505116 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1400977 | E James Dentzer | C/O Curis, Inc. 4 Maguire Road Lexington MA 02421 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-01-23 | 3,658 | $1.69 | 45,252 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-01-24 | 3,094 | $1.64 | 42,158 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares were sold pursuant to a "sell to cover" arrangement to satisfy minimum statutory tax withholding obligations related to a vesting of a service-based restricted stock award granted on January 22, 2018.
- This transaction was effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.